This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2023 Feb;23(2):112.

doi: 10.1038/s41568-022-00542-6.

Author Correction: Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Collaborators, Affiliations

Collaborators

Grand Challenge PRECISION Consortium:
Elinor J Sawyer, Helen R Davies, Andrew Futreal, Nicholas E Navin, E Shelley Hwang, Jacco van Rheenen, Fariba Behbod, Marjanka Schmidt, Lodewyk F A Wessels, Daniel Rea, Hilary Stobart, Donna Pinto, Ellen Verschuur, Marja van Oirsouw

Affiliations

¹ Department of Genetics, MD Anderson Cancer Center, Houston, TX, USA.
² Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
³ Patient Advocates in Research, Danville, CA, USA.
⁴ Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA.
⁵ Duke University Hospital, Duke University, Durham, NC, USA.
⁶ Department of Medical Genetics, University of Cambridge, Cambridge, UK.
⁷ Department of Bioinformatics, MD Anderson Cancer Center, Houston, TX, USA.
⁸ Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. j.wesseling@nki.nl.
⁹ Department of Pathology, Leiden University Medical Center, Leiden, Netherlands. j.wesseling@nki.nl.

^# Contributed equally.

PMID: 36522469
DOI: 10.1038/s41568-022-00542-6

Published Erratum

Author Correction: Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Anna K Casasent et al. Nat Rev Cancer. 2023 Feb.

. 2023 Feb;23(2):112.

doi: 10.1038/s41568-022-00542-6.

Authors

Collaborators

Grand Challenge PRECISION Consortium:
Elinor J Sawyer, Helen R Davies, Andrew Futreal, Nicholas E Navin, E Shelley Hwang, Jacco van Rheenen, Fariba Behbod, Marjanka Schmidt, Lodewyk F A Wessels, Daniel Rea, Hilary Stobart, Donna Pinto, Ellen Verschuur, Marja van Oirsouw

Affiliations

¹ Department of Genetics, MD Anderson Cancer Center, Houston, TX, USA.
² Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
³ Patient Advocates in Research, Danville, CA, USA.
⁴ Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA.
⁵ Duke University Hospital, Duke University, Durham, NC, USA.
⁶ Department of Medical Genetics, University of Cambridge, Cambridge, UK.
⁷ Department of Bioinformatics, MD Anderson Cancer Center, Houston, TX, USA.
⁸ Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. j.wesseling@nki.nl.
⁹ Department of Pathology, Leiden University Medical Center, Leiden, Netherlands. j.wesseling@nki.nl.

^# Contributed equally.

PMID: 36522469
DOI: 10.1038/s41568-022-00542-6

No abstract available

PubMed Disclaimer

Erratum for

Learning to distinguish progressive and non-progressive ductal carcinoma in situ.
Casasent AK, Almekinders MM, Mulder C, Bhattacharjee P, Collyar D, Thompson AM, Jonkers J, Lips EH, van Rheenen J, Hwang ES, Nik-Zainal S, Navin NE, Wesseling J; Grand Challenge PRECISION Consortium. Casasent AK, et al. Nat Rev Cancer. 2022 Dec;22(12):663-678. doi: 10.1038/s41568-022-00512-y. Epub 2022 Oct 19. Nat Rev Cancer. 2022. PMID: 36261705 Review.

Publication types

Actions